Our Clients
Here are our portfolio of clients. Simply click to find out more.
Here are our portfolio of clients. Simply click to find out more.
88 Energy is a multi-listed (ASX:88E,AIM:88E, OTC:EEENF) oil and gas exploration and production company with a North American focus. Read more at 88energy.com
Altech Batteries Limited (ASX:ATC), formerly Altech Chemical Ltd, is commercializing a 100 MWh solid state sodium alumina battery production facility and also developing battery materials for a Lithium-ion battery future by incorporating silicon in graphite anodes to produce higher energy density batteries.
Arovella Therapeutics (ASX: ALA) is a biotechnology company focused on developing therapies to treat human disease. Our two focus areas are oncology and conditions that impact the central nervous system. Read more at www.arovella.com
Ballymore Resources (ASX:BMR) is focused on applying modern exploration methods and development techniques to its exciting gold, copper, silver and other base metals targets located within its highly prospective projects.
BCAL Diagnostics Limited (ASX:BDX) is an Australian biotechnology company committed to improved health outcomes for women. Over the past decade, BCAL has developed a non-invasive blood screening technology that is initially intended to be used alongside breast cancer screening methods, with results to date demonstrating 90% sensitivity and 85.5% specificity. The technology will initially complement current imaging technologies, such as the mammogram, while BCAL further progresses the development of a monitoring and screening test suitable for women of all ages and backgrounds in any location. With more than two million new cases of breast cancer diagnosed globally each year, a substantial opportunity exists for BCAL to improve patient outcomes. BCAL has partnered with Precion Inc. to optimise protocols and procedures for the clinical studies required for regulatory approvals across several jurisdictions, commercialisation and market entry points. Founded in 2010, BCAL is headquartered in Sydney and listed on the Australian Securities Exchange.
CARETEQ (ASX:CTQ) is an Australian company with a focus on delivering best in class technology solutions for Health and Aged Care for a global audience. Read more at careteq.com.au
FBR designs, develops, builds and operates dynamically stabilised robots to address global needs. Read more at fbr.com.au
Foresta (NZ) Limited (ASX:FGH) manufactures pine wood pellets and pine chemicals from pine trees taken from sustainable surrounding forests.
GTI Energy is focussed on exploring for, defining and developing economic Insitu Recovery (ISR) Uranium resources – GTI Energy is part of Wyoming’s ISR uranium mining renaissance. Read more at gtienergy.au
Island Pharmaceuticals is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. We have a lead asset – ISLA-101 - that was initially developed by our wholly owned subsidiary, Isla Pharmaceuticals. ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. Dengue fever is the very definition of an unmet medical need. While 390 million humans are infected each year, it is thought that around 30-50% people with the disease do not present with symptoms, enabling the virus to spread within communities. Warming global climates are accelerating the presence of mosquito-borne viruses that can cause death to the US, Europe and Australia There is no specific pharmaceutical treatment and the one vaccine which exists is available to a highly restricted audience. Island has repurposed ISLA-101, an antiviral oral drug to treat mosquito-borne viruses (eg dengue fever / Zika) and is planning to move forward with Phase II studies with a significantly de-risked clinical program.
Lithium Universe (ASX: LU7) has a bold vision of building a Lithium resource and refinery facility in Canada that will provide the critical materials for batteries, helping the world transition towards cleaner energy. Lithium Universe is aiming to establish the Québec Lithium Processing Hub (QLPH). The QLPH is a major vertically integrated mine to battery grade lithium carbonate processing hub designed to feed the growing demand for lithium carbonate in the North American and European Battery Markets.